Rhodococcus equi in CAPD-associated peritonitis treated with azithromycin

Nephrology Dialysis Transplantation

Volumn 11, Issue 11, 1996, Pages 2340-2341

  Hoque, S ^a   Weir, A ^a   Fluck, R ^a   Cunningham, J ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Azithromycin; CAPD; Peritonitis; Rhodococcus equi

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; NETILMICIN; VANCOMYCIN;

ABDOMINAL PAIN; AGED; ARTICLE; CASE REPORT; CATHETER; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PERITONITIS; PRIORITY JOURNAL; RHODOCOCCUS EQUI;

EID: 0029949606     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027166     Document Type: Article

References (17)

1. Report of a Working Party of the British Society for Antimicrobial Chemotherapy. Diagnosis and management of peritonitis in continuous ambulatory peritoneal dialysis. Lancet 1987; 2: 845-848
2. Prescott J. Rhodococcus equi: an animal and human pathogen. Clin Microbiol Rev 1991; 4: 20-34
3. Verville T, Huycke M, Greenfield R, Fine D et al. Rhodococcus equi infections of humans. 12 cases and a review of the literature. Medicine 1994; 73: 119-32
4. Drancourt M, Bonnet E, Gallais H, Peloux Y et al. Rhodococcus equi infection in patients with AIDS. J Infect 1992; 24: 123-31
5. Franklin D, Yium J, Hawkins S. Corynebacteria equi peritonitis in a patient receiving peritoneal dialysis. South Med J 1989; 82: 1046-1047
6. Takai S, Michizoe T, Matsumura K, Nagai M et al. Correlation of in vitro properties of Rhodococcus (Corynebacteria) equi with virulence for mice. Microbiol Immunol 1985; 29: 1175-1184
7. Gladue R, Bright G, Isaacson R, Newborg M. In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanisms of delivery and release at sites of infection. Antimicrob Agents Chemother 1989; 33: 1056-1060
8. Retsema J, Bergeron J, Girard D, Milisen W et al. Preferential concentration of azithromycin in an infected mouse thigh model. J Antimicrob Chemother 1993; 31: [Suppl E] 5-16
9. Williams J. Spectrum of activity of azithromycin. Eur J Clin Microbiol Infect Dis 1991; 10: 813-820
10. Retsema J, Bergaron J, Girard D, Milisen W et al. Spectrum and mode of action of azithromycin (CP-62,993) a new 15-membered ring macrolide with improved potency against Gram-negative organisms. Antimicrob Agents Chemother 1987; 31: 1939-1947
11. Weingarten J, Huang D, Jackman J. Rhodococcus equi pneumonia. An unusual manifestation of the acquired immunodeficiency syndrome (AIDS). Chest 1988; 94: 195-196
12. Lasky J, Pulkingham N, Powers M, Durack D. Rhodococcus equi causing human pulmonary infection. Review of 29 cases. South Med J 1991; 84; 1217-1220
13. Girard A, Girard D, Retsema J. Correlation of the extravascular pharmacokinetics of azithromycin with in vivo efficacy in models of localized infection. J Antimicrob Chemother 1990; 25: [Suppl A] 73-82
14. Foulds G, Shepard R, Johnson R. The pharmacokinetics of azithromycin in human serum and tissues. J Antimicrob Chemother 1990; 25: [Suppl] A 73-82
15. Balmes P, Clerc G, Dupont B, Labram C et al. Comparative study of azithromycin and amoxyl/clavulanic acid in the treatment of lower respiratory tract infection. Eur J Clin Microbiol Infect Dis 1991; 10: 437-439
16. Lassus A, Comparative studies of azithromycin in skin and soft tissue infections and sexually transmitted infections by Neisseria and Chlamydia species. J Antimicrob Chemother 1990; 25: [Suppl A] 115-121
17. Neu H. Clinical microbiology of azithromycin. Am J Med 1991; 91: [Suppl 3A] 125-185